Literature DB >> 23224966

Function of GW182 and GW bodies in siRNA and miRNA pathways.

Bing Yao1, Songqing Li, Edward K L Chan.   

Abstract

GW182 is an 182 kDa protein with multiple glycine/tryptophan repeats (GW or WG) playing a central role in siRNA- and miRNA-mediated gene silencing. GW182 interacts with its functional partner Argonaute proteins (AGO) via multiple domains to exert its silencing activity in both pathways. In siRNA-mediated silencing, knockdown either GW182 or Ago2 causes loss of silencing activity correlating with the disassembly of GWBs. In contrast, GW182 and its longer isoform TNGW1 appear to be downstream repressors that function independent of Ago2, whereas the Ago2-GW182 interaction is critical for the localization of Ago2 in the cytoplasmic foci and its repression function. GW182 contains two non-overlapping repression domains that can trigger translational repression with mild effect on mRNA decay. Collectively, GW182 plays a critical role in miRNA-mediated gene silencing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23224966     DOI: 10.1007/978-1-4614-5107-5_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.

Authors:  Yasunari Matsuzaka; Soichiro Kishi; Yoshitsugu Aoki; Hirofumi Komaki; Yasushi Oya; Shin-Ichi Takeda; Kazuo Hashido
Journal:  Environ Health Prev Med       Date:  2014-08-24       Impact factor: 3.674

2.  Limits of using oligonucleotides for allele-selective inhibition at trinucleotide repeat sequences - targeting the CAG repeat within ataxin-1.

Authors:  Jiaxin Hu; David R Corey
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2019-10-24       Impact factor: 1.381

3.  Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.

Authors:  Jessica A Hicks; Liande Li; Masayuki Matsui; Yongjun Chu; Oleg Volkov; Krystal C Johnson; David R Corey
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

4.  Extraribosomal l13a is a specific innate immune factor for antiviral defense.

Authors:  Barsanjit Mazumder; Darshana Poddar; Abhijit Basu; Ravinder Kour; Valentina Verbovetskaya; Sailen Barik
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

5.  The Requirement for GW182 Scaffolding Protein Depends on Whether Argonaute Is Mediating Translation, Transcription, or Splicing.

Authors:  Jing Liu; Zhongtian Liu; David R Corey
Journal:  Biochemistry       Date:  2018-08-21       Impact factor: 3.162

Review 6.  Mosquito-borne viruses and suppressors of invertebrate antiviral RNA silencing.

Authors:  Scott T O'Neal; Glady Hazitha Samuel; Zach N Adelman; Kevin M Myles
Journal:  Viruses       Date:  2014-11-11       Impact factor: 5.048

Review 7.  Our Journey from the Study of Human Autoantibodies to the microRNA World.

Authors:  Kristianna M Fredenburg; Edward K L Chan
Journal:  Front Immunol       Date:  2015-03-11       Impact factor: 7.561

Review 8.  Argonaute and Argonaute-Bound Small RNAs in Stem Cells.

Authors:  Lihong Zhai; Lin Wang; Feng Teng; Lanting Zhou; Wenjing Zhang; Juan Xiao; Ying Liu; Wenbin Deng
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

9.  CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.

Authors:  Khalil Ahmed; Betsy T Kren; Md Joynal Abedin; Rachel I Vogel; Daniel P Shaughnessy; Lucas Nacusi; Vicci L Korman; Yingming Li; Scott M Dehm; Cheryl L Zimmerman; Gloria A Niehans; Gretchen M Unger; Janeen H Trembley
Journal:  Oncotarget       Date:  2016-09-20

Review 10.  Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.

Authors:  Dmitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.